Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Latini

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
European Journal of Clinical Pharmacology|January 1, 1988
Pharmacokinetics and pharmacodynamics of propafenone during acute and chronic administrationP Giani, M Landolina, V Giudici, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2008
Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary arteryS K Payeli, R Latini, C Gebhard, et al.
Acta Cardiologica|January 1, 1984
Blood levels and electrophysiological effects of intravenous amiodarone in patients with junctional reciprocating tachycardia. Preliminary observationsP Giani, A P Maggioni, A Volpi, et al.
European Heart Journal|July 4, 1998
Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: insights from the GISSI-2 studyG Zuanetti, L Mantini, F Hernández-Bernal, et al.
Diabetes Research and Clinical Practice|October 18, 2018
Incretin-based drugs and hospitalization for heart failure in the clinical practice: A nested case-control studyC Santucci, M Franchi, L Staszewsky, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Identification of propafenone metaboliser phenotype from plasma and urine excretion dataR Latini, M Belloni, R Bernasconi, et al.
European Heart Journal|February 12, 1998
Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine? GISSI experience, 1984-1993. The Gruppo Italiano di Studio sulla Sopravvivenza nell'Infarto Miocardico (GISSI) InvestigatorsF Avanzini, G Zuanetti, R Latini, et al.
The Journal of Pediatrics|August 1, 1977
Effect of exchange transfusion on elimination of theophylline in premature neonatesB M Assael, M L Caccamo, M Gerna, et al.
The American Journal of Cardiology|July 15, 1996
Trends and determinants of calcium antagonist usage after acute myocardial infarction (the GISSI experience)G Zuanetti, R Latini, F Avanzini, et al.
Toxicology Letters|September 1, 1987
Metabolism of caffeine to 6-amino-5-[N-methylformylamino]-1,3-dimethyluracil in the isolated, perfused liver from control or phenobarbital-, beta-naphthoflavone- and 3-methylcholanthrene-pretreated ratsA Guaitani, R Abbruzzi, A Bastone, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
European Journal of Clinical Pharmacology|January 1, 1988
Pharmacokinetics and pharmacodynamics of propafenone during acute and chronic administrationP Giani, M Landolina, V Giudici, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2008
Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary arteryS K Payeli, R Latini, C Gebhard, et al.
Acta Cardiologica|January 1, 1984
Blood levels and electrophysiological effects of intravenous amiodarone in patients with junctional reciprocating tachycardia. Preliminary observationsP Giani, A P Maggioni, A Volpi, et al.
European Heart Journal|July 4, 1998
Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: insights from the GISSI-2 studyG Zuanetti, L Mantini, F Hernández-Bernal, et al.
Diabetes Research and Clinical Practice|October 18, 2018
Incretin-based drugs and hospitalization for heart failure in the clinical practice: A nested case-control studyC Santucci, M Franchi, L Staszewsky, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Identification of propafenone metaboliser phenotype from plasma and urine excretion dataR Latini, M Belloni, R Bernasconi, et al.
European Heart Journal|February 12, 1998
Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine? GISSI experience, 1984-1993. The Gruppo Italiano di Studio sulla Sopravvivenza nell'Infarto Miocardico (GISSI) InvestigatorsF Avanzini, G Zuanetti, R Latini, et al.
The Journal of Pediatrics|August 1, 1977
Effect of exchange transfusion on elimination of theophylline in premature neonatesB M Assael, M L Caccamo, M Gerna, et al.
The American Journal of Cardiology|July 15, 1996
Trends and determinants of calcium antagonist usage after acute myocardial infarction (the GISSI experience)G Zuanetti, R Latini, F Avanzini, et al.
Toxicology Letters|September 1, 1987
Metabolism of caffeine to 6-amino-5-[N-methylformylamino]-1,3-dimethyluracil in the isolated, perfused liver from control or phenobarbital-, beta-naphthoflavone- and 3-methylcholanthrene-pretreated ratsA Guaitani, R Abbruzzi, A Bastone, et al.
Pageof 16